Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery
Status:
Withdrawn
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a trial of directed high-dose nasal steroids
improves residual smell loss in patients with chronic rhinosinusitis following sinus surgery.
Other outcomes of this study include: identifying the differences in sinus airflow between
patients who improve following nasal steroid treatment and those who do not, and to see if,
in patients who improve following surgery, the improvement remains throughout follow-up.